173 related articles for article (PubMed ID: 9053509)
1. Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer.
Nakamori S; Furukawa H; Hiratsuka M; Iwanaga T; Imaoka S; Ishikawa O; Kabuto T; Sasaki Y; Kameyama M; Ishiguro S; Irimura T
J Clin Oncol; 1997 Feb; 15(2):816-25. PubMed ID: 9053509
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of carbohydrate antigens, sialyl Lewis-x and sialyl Lewis-a in gastrointestinal cancer].
Nakamori S; Arai I; Okamura S; Imaoka S; Furukawa H; Kabuto T; Ishikawa O; Sasaki Y; Kameyama M; Iwanaga T
Nihon Geka Gakkai Zasshi; 1996 Feb; 97(2):165-71. PubMed ID: 8632746
[TBL] [Abstract][Full Text] [Related]
3. Sialyl-Tn antigen as a useful predictor of poor prognosis in patients with advanced stomach cancer.
Terashima S; Takano Y; Ohori T; Kanno T; Kimura T; Motoki R; Kawaguchi T
Surg Today; 1998; 28(7):682-6. PubMed ID: 9697259
[TBL] [Abstract][Full Text] [Related]
4. Fucosyltransferase-producing sialyl Le(a) and sialyl Le(x) carbohydrate antigen in benign and malignant gastrointestinal mucosa.
Dohi T; Hashiguchi M; Yamamoto S; Morita H; Oshima M
Cancer; 1994 Mar; 73(6):1552-61. PubMed ID: 7908856
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer.
Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169
[TBL] [Abstract][Full Text] [Related]
6. Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis.
Nakamori S; Kameyama M; Imaoka S; Furukawa H; Ishikawa O; Sasaki Y; Izumi Y; Irimura T
Dis Colon Rectum; 1997 Apr; 40(4):420-31. PubMed ID: 9106690
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of T antigen expression in patients with gastric carcinoma.
Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M
Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672
[TBL] [Abstract][Full Text] [Related]
8. Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis.
Lundin M; Nordling S; Roberts PJ; Lundin J; Carpelan-Holmström M; von Boguslawsky K; Haglund C
Oncology; 1999 Jul; 57(1):70-6. PubMed ID: 10394128
[TBL] [Abstract][Full Text] [Related]
9. Expression of sialyl-Tn antigen is correlated with survival time of patients with gastric carcinomas.
Ma XC; Terata N; Kodama M; Jancic S; Hosokawa Y; Hattori T
Eur J Cancer; 1993; 29A(13):1820-3. PubMed ID: 8260233
[TBL] [Abstract][Full Text] [Related]
10. Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer.
Yu CJ; Shih JY; Lee YC; Shun CT; Yuan A; Yang PC
Lung Cancer; 2005 Jan; 47(1):59-67. PubMed ID: 15603855
[TBL] [Abstract][Full Text] [Related]
11. Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer.
Victorzon M; Nordling S; Nilsson O; Roberts PJ; Haglund C
Int J Cancer; 1996 Jan; 65(3):295-300. PubMed ID: 8575847
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
13. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
15. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
Fujimoto D; Goi T; Hirono Y
Int J Oncol; 2017 Feb; 50(2):448-456. PubMed ID: 28035352
[TBL] [Abstract][Full Text] [Related]
16. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.
Laack E; Nikbakht H; Peters A; Kugler C; Jasiewicz Y; Edler L; Brümmer J; Schumacher U; Hossfeld DK
J Clin Oncol; 2002 Nov; 20(21):4279-84. PubMed ID: 12409325
[TBL] [Abstract][Full Text] [Related]
17. Alterations in gastric mucin with malignant transformation: novel pathway for mucin synthesis.
Yamashita Y; Chung YS; Horie R; Kannagi R; Sowa M
J Natl Cancer Inst; 1995 Mar; 87(6):441-6. PubMed ID: 7532228
[TBL] [Abstract][Full Text] [Related]
18. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
19. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
